Nasdaq Reports Third Quarter 2020 Results; Delivers Broad-Based 13% Revenue Growth vs. Prior Year Period
Go back to Nasdaq Reports Third Quarter 2020 Results; Delivers Broad-Based 13% Revenue Growth vs. Prior Year Period| Elite Pharmaceuticals (NASDAQ: LI) | Delayed: 12.37 +0.31 (2.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.06 | 52 Week High | $35.22 | |||
| Open | $12.21 | 52 Week Low | $0.98 | |||
| Day High | $12.48 | P/E | N/A | |||
| Day Low | $12.19 | EPS | $-0.86 | |||
| Volume | 2,734,274 | |||||
| NASDAQ OMX Group (NASDAQ: NDAQ) | Delayed: 96.88 -1.83 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.71 | 52 Week High | $71.92 | |||
| Open | $97.14 | 52 Week Low | $54.62 | |||
| Day High | $97.49 | P/E | 43.06 | |||
| Day Low | $96.57 | EPS | $2.25 | |||
| Volume | 2,237,519 | |||||
